153039-17-9

Usage

Uses

Used in Pharmaceutical Industry:
4-BOC-AMINO-2,2-DIMETHYLBUTYRIC ACID is used as a building block for the synthesis of various pharmaceuticals and biochemicals. Its unique structure and properties make it a valuable intermediate in the production of peptides and other complex molecules.
Used in Research and Development:
4-BOC-AMINO-2,2-DIMETHYLBUTYRIC ACID is used as a reagent in the synthesis of novel compounds for research and development in the pharmaceutical industry. Its versatility and reactivity contribute to the discovery and development of new drugs and therapeutic agents.

InChI:InChI=1/C11H21NO4/c1-10(2,3)16-9(15)12-7-6-11(4,5)8(13)14/h6-7H2,1-5H3,(H,12,15)(H,13,14)

Upstream product

• 153039-16-8 tert-butyl 3,3-dimethyl-2-oxo-pyrrolidine-1-carboxylate 

Downstream Products

• 937709-81-4 tert-butyl 4-((trans,trans)-4-(3-fluoro-2-methylphenyl)-3,5-bis(3-methoxybenzoyl)piperidin-1-yl)-3,3-dimethyl-4-oxobutylcarbamate 

Relevant academic research and scientific papers

4-AMINO OR 4-ALKOXY-SUBSTITUTED ARYL SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

Disclosed are compounds of Formula (I), Formula (II), or a salt thereof: Formula (I) Formula (II) which compounds have properties for inhibiting Nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula (I), Formula (II) or their salts, and methods of treating pain disorders, cough, and itch using the same.

EXTERNALLY MASKED NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE

Masked nitrogen-substituted and oxygen-substituted neopentyl sulfonyl ester prodrugs of acamprosate, pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In particular, acamprosate prodrugs exhibiting enhanced oral bioavailability and methods of using acamprosate prodrugs to treat neurodegenerative disorders, psychotic disorders, mood disorders, anxiety disorders, somatoform disorders, movement disorders, substance abuse disorders, binge eating disorder, cortical spreading depression related disorders, tinnitus, sleeping disorders, multiple sclerosis, and pain are disclosed.